Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Lexagene Potential Monthly Income From Test Sales

<< Previous

Bullboard Posts

Next >>

Comment by ragb7002on May 20, 2020 3:55pm

77 Views

Post# 31052967

RE:RE:RE:RE:Lexagene Potential Monthly Income From Test Sales

YOUR ENTIRE PREMISE FALLS FLAT IF YOU DONT HAVE AN ACTUAL SALES NUMBER. BIG DIFFERENCE BETWEEN 5-20-40-60. YOUR NEXT QUESTION WOULD BE HOW MANY CAN THEY ACTUALLY MAKE? I LIKE YOU ARE HOPEING FOR THE BEST, BUT THE COMPANY HAS RELEASED NO MANUFACTURING OR SALES NUMBERS. WE ARE ALL WAITING: DON'T HOLD YOUR BREATH!!

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly